期刊文献+

麝香保心丸对肝硬化大鼠心肌组织即早基因与结缔组织生长因子的影响 被引量:2

Effects of Shexiang Baoxin Pills on myocardial tissue immediate early gene and connective tissue growth factor in rats with hepatic cirrhosis
原文传递
导出
摘要 目的研究麝香保心丸对肝硬化致心肌重构的抑制作用及其机制。方法以sc体积分数40%CCl4橄榄油溶液3mL/kg,每周2次,共8周的方法制备大鼠肝纤维化模型,第2周末随机取5只大鼠肝组织作HE染色,观察肝纤维化程度,造模大鼠分别ig麝香保心丸22.5、45 mg/kg,共给药6周,第8周末分别取各组大鼠肝组织、左室心肌组织行组织病理学及透射电镜观察,观察各组大鼠肝脏、心肌组织病理及心肌组织超微结构改变;以RT-PCR和免疫组化染色分析心肌组织中c-fos和c-jun mRNA以及结缔组织生长因子(CTGF)、I型和III型胶原的表达变化。结果造模大鼠均存在不同程度的肝纤维化及心肌损伤。与模型组比较,低剂量麝香保心丸组大鼠肝纤维化程度无明显差异(P>0.05),但心肌损伤程度减轻,心肌组织中c-fos mRNA、c-jun mRNA、CTGF、I型和III型胶原表达明显降低(P<0.05、0.01)。高剂量麝香保心丸组大鼠肝纤维化及心肌损伤程度较低剂量组减轻(P<0.05),心肌组织中c-fos mRNA、c-jun mRNA、CTGF、I型和III型胶原表达均低于低剂量组(P<0.05、0.01)。结论肝硬化大鼠心肌组织心肌即早基因活化、诱导CTGF过度表达而致心肌重构,麝香保心丸可通过抑制心肌即早基因表达,降低心肌CTGF水平而发挥心肌保护作用,其效应呈剂量依赖性。 Objective To investigate the inhibition of Shexiang Baoxin Pills(SBP) on myocardium reconstruction due to hepatic cirrhosis and its mechanism.Methods Model of hepatic cirrhosis rats was established by sc injection with 40% CCl4 of olive oil solution(3 mL/kg,twice a week for eight weeks).After two weeks of the first injection,five rats were executed to confirm the formation of hepatic fibrosis by HE staining,and the rest of rats were randomly and equally divided into model,low-,and high-dose SBP groups.Low-and high-dose groups were respectively ig administrated with SBP at volumes of 22.5 and 45 mg/(kg.d) for six weeks,whereas the rats of model group were not given any treatment.At the end of the 8th week,all rats were sacrificed and a part of liver tissue and myocardium tissue were preserved.Transmission electron microscope(TEM) technique was applied to observing the changes of hepatic and cardiac histopathology and myocardial ultramicrostructure;RT-PCR and immunohistochemical techniques were applied to analyzing the expression of myocardial c-fos mRNA,c-jun mRNA,and the contents of myocardial connective tissue growth factor(CTGF),types I and III collagen in all groups.Results Hepatic fibrosis and myocardial injury were in different degrees among the three groups.Compared to model group,low-dose SBP treatment could not relieve the degree of hepatic fibrosis(P 0.05).The degree of myocardial injury and the content of myocardial c-fos and c-jun mRNA,CTGF as well as types I and III collagen were obviously reduced(P 0.05,0.01).Compared to low-dose group,the degrees of hepatic fibrosis and myocardial injury were further relieved(P 0.05) and the content of myocardial c-fos and c-jun mRNA,CTGF as well as types I and III collagen were reduced significantly with high-dose SBP treatment(P 0.05,0.01).Conclusion Hepatic cirrhosis in rats may lead to myocardium reconstruction by stimulating the expression of immediate early gene and promoting the overexpression of CTGF in myocardium.SBP may protect myocardium through inhibiting the expression of myocardial immediate early gene,which could decrease the level of myocardial CTGF in a dose-dependent manner.
出处 《中草药》 CAS CSCD 北大核心 2012年第5期940-946,共7页 Chinese Traditional and Herbal Drugs
关键词 麝香保心丸 肝纤维化 心肌重构 即早基因 结缔组织生长因子 Shexiang Baoxin Pills(SBP) hepatic cirrhosis myocardium reconstruction immediate early gene connective tissue growth factor(CTGF)
  • 相关文献

参考文献13

  • 1Zardi E M, Abbate A, Zardi D M, et al. Cirrhotic cardiomyopathy [J]. J Am Coil Cardiol, 2010, 56(7): 539-549.
  • 2杜文惠,彭风芹,谢素屏,王平,王继红,刘玉锐,杨永进,樊向明,何云霞,郝鸿博.麝香保心丸对急性心肌梗死患者左室重构的影响[J].中国中西医结合杂志,2011,31(2):268-269. 被引量:23
  • 3Ceolotto G, Papparella I, Sticca A, et al. An abnormal gene expression of the beta-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats [J]. Hepatology, 2008, 48(6): 1913-1923.
  • 4曹芳芳,李艳芳,刘飞,白雪源,吕杨.麝香保心丸对心力衰竭大鼠心脏血管紧张素受体的影响[J].心肺血管病杂志,2011,30(3):241-245. 被引量:10
  • 5A1-Hamoudi W K. Cardiovascular changes in cirrhosis: Pathogenesis and clinical implications [J]. Saudi J Gastroenterol, 2010, 16(3): 145-153.
  • 6Moiler S, Henriksen J H. Cirrhotic cardiomyopathy [J]. J Hepatol, 2010, 53(1): 179-190.
  • 7王毅峰,殷亮,刘随意,王志农.结缔组织生长因子对心肌修复的研究[J].医学综述,2010,16(16):2436-2438. 被引量:2
  • 8Urso C, Caimi G. Oxidative stress and endothelial dysfunction [J]. Minerva Med, 2011, 102(1): 59.
  • 9Munshi M K, Uddin M N, Glaser S S. The role of the renin-angiotensin system in liver fibrosis [J]. Exp Biol Med (Maywood), 2011, 236(5): 557-566.
  • 10Cavasin M A, Semus H, Pitts K, et al. Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats [J]. Can J Physiol Pharmacol, 2010, 88(6): 636-643.

二级参考文献70

共引文献46

同被引文献37

  • 1田柱萍,何邦平,王小燕,林锦明.中药材的药效与其所含微量元素关系的研究进展[J].微量元素与健康研究,2005,22(4):54-56. 被引量:110
  • 2潘璠,李思汉.锌铜与动脉粥样硬化[J].微量元素与健康研究,1995,12(3):58-59. 被引量:5
  • 3程薇莉,林云卿.老年糖尿病、冠心病及高脂血症患者血清中微量元素含量的测定[J].微量元素与健康研究,1995,12(4):15-16. 被引量:12
  • 4王懿萍,张小荣,杨巧艳,王盛民.中药微量元素与药效的关系[J].陕西中医,2006,27(12):1573-1576. 被引量:90
  • 5Toda K, Kumagai N, Kaneko F, et al. Pentoxifyllineprevents pig serum-induced rat liver fibrosis by inhibiting interleukin-6 production [J]. J Gastroenterol Hepatol, 2009, 24(5): 860-865.
  • 6Zhao X Y, Zeng X, Li X M, et al. Pirfenidone inhibits carbon tetrachloride-and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells [J]. Clin Exp Pharmaeol Physiol, 2009, 36 (10): 963-968.
  • 7Lee U E, Friedman S L. Mechanisms of hepatic fibrogenesis [J]. Best Praet Res Clin Gastroenterol, 2011, 25(2): 195-206.
  • 8Rosmorduc O, Housset C. Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease [J]. Semin Liver Dis, 2010, 30(3): 258-270.
  • 9Novo E, Cannito S, Zamara E, et al. Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells [J]. Am JPathol, 2007, 170(6): 1942-1953.
  • 10Liu Y, Lui E L, Friedman S L, et al. PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling [J]. Lab Invest, 2009, 89(2): 209-221.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部